Measuring patient activation: the utility of the Patient Activation Measure administered in an interview setting

被引:4
|
作者
Holter, Magdalena [1 ]
Avian, Alexander [1 ]
Weger, Martin [2 ]
Strini, Sanja [2 ]
Michelitsch, Monja [2 ]
Brenk-Franz, Katja [3 ]
Wedrich, Andreas [2 ]
Berghold, Andrea [1 ]
机构
[1] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria
[2] Med Univ Graz, Dept Ophthalmol, Graz, Austria
[3] Jena Univ Hosp, Inst Psychosocial Med Psychotherapy & Psychooncol, Jena, Germany
关键词
Patient Activation Measure (R); Psychometrics; Item response theory; Mode of questionnaire administration; ITEM RESPONSE THEORY; PSYCHOMETRIC PROPERTIES; HEALTH-STATUS; VALIDATION; PEOPLE; DEPRESSION; OUTCOMES; MODE; CARE;
D O I
10.1007/s11136-024-03614-2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Patient activation is an emerging field in healthcare research concerning knowledge, skills, and confidence of patients in managing their health. This is particularly important for patients with chronic diseases, who often require more complex care management and self-care skills. However, due to temporary or longer-lasting visual impairments, certain patient groups cannot answer a questionnaire independently. The main objective is to investigate the psychometric properties of the German Patient Activation Measure (R) (PAM) survey in an everyday clinical setting where it has to be read aloud. Methods Outpatients with macular edema participated in this questionnaire-based cross-sectional study. The study assessed patient activation by the PAM (R) survey, self-rated health, self-efficacy, quality of life, and general mood. Interviewers read questionnaires aloud to patients. Psychometric properties of the PAM (R) survey were investigated by item response theory (IRT), Cronbach's alpha and trait-trait correlations. Results The analysis included N = 554 patients. Median age was 69 (IQR 62.0-76.0) years and mean overall activation score 74.1 (SD 13.7). All items showed ceiling effects. Empirical reliability from the IRT model and Cronbach's alpha were 0.75. The PAM (R) survey showed a Spearman correlation of 0.54 with self-efficacy, 0.51 with quality of life and 0.34 with general mood. Conclusion The read-aloud PAM (R) survey has been shown to provide to adequate measurement precision and convergent validity to be used as a screening tool in an everyday clinical setting. Objective assessment in an interview setting with the PAM (R) survey is possible. PAM (R) items are good in distinguishing lower to middle activated patients, but not patients with high activation. Further, issues with structural validity need more investigation.
引用
收藏
页码:1389 / 1400
页数:12
相关论文
共 50 条
  • [1] Measuring patient activation: the utility of the Patient Activation Measure administered in an interview setting
    Magdalena Holter
    Alexander Avian
    Martin Weger
    Sanja Strini
    Monja Michelitsch
    Katja Brenk-Franz
    Andreas Wedrich
    Andrea Berghold
    Quality of Life Research, 2024, 33 : 1389 - 1400
  • [2] Rheumatology patients' perceptions of patient activation and the Patient Activation Measure: A qualitative interview study
    Jones, Bethan
    Hunt, Andrew
    Hewlett, Sarah
    Harcourt, Diana
    Dures, Emma
    MUSCULOSKELETAL CARE, 2022, 20 (01) : 74 - 85
  • [3] The Malay Version of Patient Activation Measure: An Instrument for Measuring Patient Engagement in Healthcare
    Hashim, Syahnaz Mohd
    Idris, Idayu Badilla
    Sharip, Shalisah
    Bahari, Rafidah
    Jahan, Nasrin
    SAINS MALAYSIANA, 2020, 49 (10): : 2487 - 2497
  • [4] Validation of the Brazilian Version of the Patient Activation Measure 13
    Cunha, Cristiane Martins
    Previde Teixeira da Cunha, Debora Cristine
    Manzato, Rafaela de Oliveira
    Nepomuceno, Eliane
    da Silva, Dirceu
    Spadoti Dantas, Rosana Aparecida
    JOURNAL OF NURSING MEASUREMENT, 2019, 27 (01) : 97 - 113
  • [5] Reliability and Validity of the Patient Activation Measure in Kidney Disease
    Lightfoot, Courtney J.
    Wilkinson, Thomas J.
    Memory, Katherine E.
    Palmer, Jared
    Smith, Alice C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (06): : 880 - 888
  • [6] Measuring patient activation in Italy: Translation, adaptation and validation of the Italian version of the patient activation measure 13 (PAM13-I)
    Graffigna, Guendalina
    Barello, Serena
    Bonanomi, Andrea
    Lozza, Edoardo
    Hibbard, Judith
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2015, 15
  • [7] The Patient Activation Measure: a validation study in a neurological population
    Packer, Tanya L.
    Kephart, George
    Ghahari, Setareh
    Audulv, Asa
    Versnel, Joan
    Warner, Grace
    QUALITY OF LIFE RESEARCH, 2015, 24 (07) : 1587 - 1596
  • [8] The Patient Activation Measure-13 (PAM-13) in an oncology patient population: psychometric properties and dimensionality evaluation
    Roesel, Inka
    Froehlich, Daniela
    Joos, Stefanie
    Valentini, Jan
    Mauch, Holger
    Martus, Peter
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2024, 22 (01)
  • [9] The Patient Activation Measure in Patients with Rheumatoid Arthritis: A Systematic Review and Cross-Sectional Interview-Based Survey
    Al Juffali, Lobna
    Almalag, Haya M.
    Alswyan, Najd
    Almutairi, Jawaher
    Alsanea, Dalal
    Alarfaj, Hussain F.
    Alarfaj, Abdurhman S.
    Abouzaid, Hanan H.
    Omair, Mohammed A.
    PATIENT PREFERENCE AND ADHERENCE, 2022, 16 : 2845 - 2865
  • [10] Measuring Patient Activation as Part of Kidney Disease Policy: Are We There Yet?
    Nair, Devika
    Cavanaugh, Kerri L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (07): : 1435 - 1443